We provide the first evidence that the CatE‐sTRAIL axis contributes to cross‐talk between microglia and neurons in the progression of AD, and that targeting CatE with GV resulted in significant functional recovery in AD mice. This evidence concerns the gene CTSE and Alzheimer disease.